Month: August 2022

CellSeed: soon clinical trial of allogenic bone cell sheets for knee osteoarthritis treatment The company plans to start clinical trials in 2023 for allogeneic soft bone cell sheets for knee osteoarthritis. CellSeed develops regenerative medical products based on a technology invented by Professor Mitsuo Okano of Tokyo Women’s Medical University that enables cells to be cultured in sheet form. While selling cell culture equipment, the company is […]

Kyoto startup Symbiobe produces spider silk in recombinant marine phototrophic bacteria Symbiobe is a Kyoto University startup commercializing technology for bio refineries based on marine photosynthetic bacteria. Technology is based on the research results of Professor Keiji Numata of the Department of Materials Chemistry, Kyoto University. Using carbon dioxide and atmospheric nitrogen as raw materials, the company plans to develop four businesses: (1) services […]

Toray ready to scale technology for 100 % bio-based adipic acid Adipic acid is a key material for the production of polyamide 66 (nylon). Unlike petroleum-derived adipic acid, bio adipic acid synthesized by this method does not emit any nitrous oxide (N2O). Toray Industries, with support from NEDO, is developing a highly efficient microbial fermentation process based on metabolically engineered Pseudomonas strain and an energy-saving purification method […]

2022/08 A microarray measures COVID antibody levels in blood in 8 minutes The system developed by a joint research group from the RIKEN Center for Emergent Matter Science and Chiba University Graduate School of Medicine uses a synthetic polymer that is photoreactive and inhibits nonspecific adsorption which is coated on a chip, and viral proteins are placed on the chip in the form of spots. The […]

Microbiome bacteria frequent in Japanese reduce obesity and diabetes symptoms in diabetic mice A Japanese team has found bacteria in the microbiome of Japanese people that may improve obesity and diabetes symptoms in a joint study with Waseda University and others. In a cohort study, Blautia wexlerae was identified as an intestinal bacterium that is less common in obese and type 2 diabetic Japanese and more common […]

Scroll to top